Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Oct 22, 2017 at 10:45 AM EDT

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

At least eight large biotech and pharma outfits are scheduled to report their latest earnings and revenues this coming week.

Paul Ausick | Oct 20, 2017 at 10:35 AM EDT

Polluted Air, Water Cost 9 Million Lives in 1 Year

In 2015, 9 million people died prematurely as a result of pollution. That's 16% of all human deaths worldwide for…

Jon C. Ogg | Oct 19, 2017 at 12:15 PM EDT

Does Gilead’s CAR T Approval Vindicate the High Acquisition Price for Kite Pharma?

Now there is a new FDA approval Gilead's CAR T lymphoma treatment named Yescarta that has created at least some…

Lee Jackson | Oct 19, 2017 at 8:30 AM EDT

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

These four top companies all have data that could move the shares the rest of this year and into 2018.…

Jon C. Ogg | Oct 18, 2017 at 2:10 PM EDT

Will Eli Lilly’s mRNA Cancer Vaccine Investment Hit Paydirt?

With Eli Lilly making a huge headline investment in a cancer vaccine, 24/7 Wall St. wanted to look under the…

Jon C. Ogg | Oct 18, 2017 at 11:40 AM EDT

Analysts Piling On to Raise Johnson & Johnson Price Targets Higher and Higher

24/7 Wall St. tracks key analyst calls in the stocks that move the markets and which are important to investors.…

Chris Lange | Oct 18, 2017 at 8:50 AM EDT

Why Spectrum Pharmaceuticals Shares Are Surging

Spectrum Pharmaceuticals saw its shares make a solid gain early on Wednesday after the firm announced interim data from its…

Paul Ausick | Oct 17, 2017 at 11:00 AM EDT

UnitedHealth Profits Jump, Raises EPS Estimate

UnitedHealth Group beat EPS and revenue estimates for the third quarter despite a sharp hit related to withdrawing from the…

Chris Lange | Oct 17, 2017 at 9:40 AM EDT

Johnson & Johnson Pharmaceutical, Domestic Sales Fuel Growth

Johnson & Johnson reported better-than-expected fiscal third-quarter financial results before the markets opened on Tuesday.

Chris Lange | Oct 16, 2017 at 9:10 AM EDT

Exelixis Cancer Treatment Hits Key Milestone

Exelixis kicked off the week with a couple updates that are already having a big impact on the stock. These…

Chris Lange | Oct 13, 2017 at 10:45 AM EDT

Is Spark Therapeutics’ Luxturna a Game Changer?

Shares of Spark Therapeutics saw a handy gain to close out the week after the FDA recommended approval of Luxturna.

Jon C. Ogg | Oct 12, 2017 at 2:05 PM EDT

Are Analysts Secretly Calling Gilead a Screaming Buy?

Sometimes it turns out that great growth companies eventually run into the day when getting the growth of the past…

Chris Lange | Oct 12, 2017 at 10:45 AM EDT

Why Infinity Pharmaceuticals Shares Are Surging

Infinity Pharmaceuticals saw its shares almost double early on Thursday after the company announced good news.

Chris Lange | Oct 11, 2017 at 11:35 AM EDT

Short Sellers Grow More Selective on Major Biotechs

The September 29 short interest data have been compared with the previous report, and short interest in the selected biotech…

Chris Lange | Oct 11, 2017 at 10:55 AM EDT

Short Sellers Run for Cover From Major Pharma

The September 29 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 152 153 154 155 156 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

Polluted Air, Water Cost 9 Million Lives in 1 Year

Does Gilead’s CAR T Approval Vindicate the High Acquisition Price for Kite Pharma?

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

Will Eli Lilly’s mRNA Cancer Vaccine Investment Hit Paydirt?

Analysts Piling On to Raise Johnson & Johnson Price Targets Higher and Higher

Why Spectrum Pharmaceuticals Shares Are Surging

UnitedHealth Profits Jump, Raises EPS Estimate

Johnson & Johnson Pharmaceutical, Domestic Sales Fuel Growth

Exelixis Cancer Treatment Hits Key Milestone

Is Spark Therapeutics’ Luxturna a Game Changer?

Are Analysts Secretly Calling Gilead a Screaming Buy?

Why Infinity Pharmaceuticals Shares Are Surging

Short Sellers Grow More Selective on Major Biotechs

Short Sellers Run for Cover From Major Pharma

If You Had Invested $1,000 in McDonald’s a Decade Ago: A Prospective Dividend King’s Long-Term Payoff

We May Soon Find Out Why Warren Buffett and Berkshire Hathaway Have Almost $400 Billion in Cash

Prospect Capital insiders are buying while yield hunters debate the safety

Caleb Hammer Confronts Husband Hiding an AI Girlfriend From His Wife

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

If You Had Invested $1,000 in McDonald’s a Decade Ago: A Prospective Dividend King’s Long-Term Payoff

We May Soon Find Out Why Warren Buffett and Berkshire Hathaway Have Almost $400 Billion in Cash

Health and Healthcare Articles

All Health and Healthcare Articles

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

Polluted Air, Water Cost 9 Million Lives in 1 Year

Does Gilead’s CAR T Approval Vindicate the High Acquisition Price for Kite Pharma?

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

Will Eli Lilly’s mRNA Cancer Vaccine Investment Hit Paydirt?

Analysts Piling On to Raise Johnson & Johnson Price Targets Higher and Higher

Why Spectrum Pharmaceuticals Shares Are Surging

UnitedHealth Profits Jump, Raises EPS Estimate

Johnson & Johnson Pharmaceutical, Domestic Sales Fuel Growth

Exelixis Cancer Treatment Hits Key Milestone

Is Spark Therapeutics’ Luxturna a Game Changer?

Are Analysts Secretly Calling Gilead a Screaming Buy?

Why Infinity Pharmaceuticals Shares Are Surging

Short Sellers Grow More Selective on Major Biotechs

Short Sellers Run for Cover From Major Pharma

If You Had Invested $1,000 in McDonald’s a Decade Ago: A Prospective Dividend King’s Long-Term Payoff

We May Soon Find Out Why Warren Buffett and Berkshire Hathaway Have Almost $400 Billion in Cash

Prospect Capital insiders are buying while yield hunters debate the safety

Featured Reads

Caleb Hammer Confronts Husband Hiding an AI Girlfriend From His Wife

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70